Infringement of patents

The fourth and fifth patents on which GSK sued Apotex were product-by-process patents, raising the listing issues described in Appendix H. GSK s fourth suit was for infringement of Patent No. 

Incremental investments, 315-329 Index name, 893 subject, 897 Indexes, cosf 163-166 Indirect costs, 210 in capital investments, 160, 167 Inflation, 295 strategy for, 408-413 tax effects on, 410-413 Informal reports, definition of 453- 454 Infringements of patents, 102 Installation costs for equipmenf 171-172 Instrumentation cost of 172-173, 812-814 plant requirements for, 97 Insulation cost of 172 for pipe, 513 Insurance, 262-265 as a cost, 253, 262 cost of 205, 210 Intalox saddles, 688, 690, 694 cost of 710 Interest ... 

In evaluating product information during prequalification and during tendering, information regarding the patent status should be requested. No infringement of patents by any United Nations or other procurement agency should occur. 

Suits for the infringement of patents must be instituted in national tribunals. Infringement of a national patent issued from a European patent is dealt with under the national law of the contracting states and may be heard by the national... 

An indispensable legal aspect for the generic industry is the so-called Roche-Bolar -type exemptions or Bo-lar provisions. So far, I have only considered infringement of patents by the substance itself or by methods used. However, even if a substance or method infringes the claims of a patent, there are exceptions that... 

When evaluating an issued patent for purposes of determining the patentabiUty of a new invention, the entire patent must be considered. As a result, the figures, K, and The Detailed Description of the Preferred Embodiment, Q, are every bit as important to an issued patent as the claims, S. At certain times any one of these elements may become more relevant than another. For example, claims tend to be more relevant to deterrninations of patent infringement or violation. However, in deterrninations concerning the patentabiUty of new inventions, the figures, K, and The Detailed Description of the Preferred Embodiment, Q, may be the most relevant aspects of any previous patent. 

Issuance of a United States patent transforms a patent appHcant into a patentee, and new concerns may arise relevant to management. For example, the patent should be reviewed to determine formal and substantive correctness. An audit should be taken regularly to determine whether there is a continuing justification to pay the maintenance fees required to keep the patent in force during its effective period. The patentee or patent assignee may have to address concerns of patent infringement or patent vaHdity. 

The bulk of the patent specification is the disclosure, the text and illustrations that describe the claimed invention in detail and explain how the claimed invention differs from the prior art. Modem patent disclosures contain a summary of the claimed invention, a description of the background of the invention, a general description of the way in which the invention is made and used, specific examples, and, where appHcable, drawings of the invention in general or specific embodiments. The technical information provided in a patent specification may be used without infringing the patent only practicing the invention defined in the claims within the term and territory of the patent grant is forbidden. Because much of the information in patent specifications is never pubHshed in refereed journals or other nonpatent media, patent disclosures are an invaluable part of the technical Hterature. 

Infringement Searching. An individual or organization found to be infringing the patent rights of others is subject to penalties that can be extremely costiy. It is essential for anyone contemplating a commercial venture that is technology-dependent to find out first whether or not the proposed venture falls within the area covered by adversely held patents. 

Infringement of a patent occurs when an individual or company makes, uses, or sells an invention without the permission of the inventor, assignee, owner, or licensee. The U.S. courts will award damages and place penalties on the infringer. But patent infringement cases are very costly and time consuming. 

Nothing contained in any API publication is to be construed as granting any right, by implication or otherwise, for the manufacture, sale, or use of any method, apparatus, or product covered by letters patent. Neither should anything contained in the publication be construed as insuring anyone against liability for infringement of letters patent. 

Most medicinal chemists have a basic understanding of patents. This chapter assumes and builds upon this basic knowledge by analyzing court cases where patent owners took suspected infringers to court. It highlights a variety of defenses employed by the suspected infringers to operate outside the scope of, invalidate, or render unenforceable, the asserted patent(s). 

ASME does not take any position with respect to the validity of any patent rights asserted in connection with any items mentioned in this document, and does not undertake to insure anyone utilizing a standard against liability for infringement of any applicable letters patent, nor assumes any such liability. Users of a code or standard are expressly advised that determination of the validity of any such patent rights, and the risk of infringement of such rights, is entirely their own responsibility. 

Anyone utilizing this information assumes all liability arising from such use, including but not limited to infringement of any patent or patents. 

Another new provision in Section 271 provides that a patented invention, if substantially completed within the United States and then finally completed elsewhere, cannot avoid infringement of the U.S. patent. This is a useful clause because a recent U.S. court decision had held that all aspects of a patented invention must be practiced within the United States in order to infringe the U.S. patent. It now remains for the courts to decide what is meant by substantially completed. ... 

---